Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The old but reliable digitalis: persistent concerns and expanded indications.

R F Abarquez1

  • 1College of Medicine, University of the Philippines, Manila, Philippines.

International Journal of Clinical Practice
|April 27, 2001
PubMed
Summary

Digitalis, a long-standing medication, shows benefits in heart failure hospitalization and prevention of cardiac issues in hypertension. However, its impact on all-cause mortality and in conditions like acute myocardial infarction remains under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The dynamic exercise electrocardiogram.

Journal of the American Geriatrics Society·2014
Same author

Management options for hypertension syndrome.

International journal of clinical practice·2001
Same author

Efficacy of slow-release oral isradipine in moderate-to-severe hypertension with add-on spirapril.

American journal of hypertension·1993
Same author

Isradipine dose-confirmation study in Filipino patients with mild to moderate hypertension.

Drugs·1990
Same author

Digitalis in the treatment of hypertension. A prelminary report.

Acta medica Philippina·1967
Same author

Comparative sensitivities of the dynamic exercise ECG, post exercise ECG and combined ECG tests among Filipino coronary patients.

Journal of the Philippine Medical Association·1966

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Digitalis is a well-established medication with a 240-year history.
  • Ongoing debate exists regarding its clinical indications and overall benefits, particularly concerning all-cause mortality.
  • While its use in atrial fibrillation is standard, its role in sinus rhythm is still debated.

Purpose of the Study:

  • To evaluate the established and speculative clinical benefits of digitalis.
  • To assess the impact of digitalis on mortality and hospitalization in heart failure.
  • To explore the potential of digitalis in managing uncomplicated hypertension and preventing related cardiac events.

Main Methods:

  • Review of existing clinical data and studies, including the Digitalis Investigation Group (DIG) study.

Related Experiment Videos

  • Analysis of digitalis's effects on different cardiac conditions such as atrial fibrillation, sinus rhythm, congestive heart failure, and hypertension.
  • Assessment of digitalis's influence on acute myocardial infarction, coronary artery disease, and sudden cardiac death.

    • Main Results:

    • The Digitalis Investigation Group (DIG) study demonstrated a significant reduction in death and heart failure hospitalizations for both diastolic and systolic dysfunction.
    • Digitalis use in uncomplicated hypertension may prevent left ventricular dysfunction and myocardial infarction.
    • The drug's influence on acute myocardial infarction, coronary artery disease, and sudden cardiac death remains speculative.

    Conclusions:

    • Digitalis remains a valuable therapeutic option, particularly in managing heart failure and hypertension.
    • Further research is needed to clarify its role in acute coronary syndromes and its impact on all-cause mortality.
    • Digitalis presents a cost-effective treatment option with potential added cardiovascular benefits.